3 employees
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.
2021
$541K
from 2 investors over 2 rounds
Aukera Therapeutics raised $151K on October 11, 2022
Investors: Venture Kick
Aukera Therapeutics raised $541K on February 15, 2022
Investors: BaseLaunch